Vetoquinol Corporate brochure 2016

Achieve more together 16 2015 HIGHLIGHTS FIRST STEPS IN JAPAN Vetoquinol and Nippon Zenyaku Kogyo Co., Ltd., which operates under the trade name «Zenoaq», have ente- red into a joint venture agreement to develop, register and market a range of animal health products in Japan. ACHIEVE MORE TOGETHER Vetoquinol first launched its new identity among its employees: each subsidiary and each entity worked together to establish how it wanted to interpret this tagline practically within its teams. The internal launches also provided opportunities for get-togethers, unique creations and ever more productive discussions. UPCARD ® Vetoquinol is innovating in the field of cardiology with the launch of Upcard © , the first torasemide-based diuretic registered for veterinary use, thereby strengthening its product offering in the field of animal cardiology. Heart disease is common in dogs and is becoming increasingly common as dogs are now living longer. Most treatments must be adminis- tered several times a day and for the remainder of the animal’s life, and this causes considerable inconvenience to pet owners. The launch of this product was accom- panied by training which has been given to our veterinary customers throughout the world. “This new reference product is a valuable addition to our offering and is fully in line with the implementation of our strategy“.